Cardiome completes up to USD22m in senior, secured term loan facility
M2 - Mon Jul 21, 7:13AM CDT
Pharmaceutical company Cardiome Pharma (NASDAQ:CRME)(TSX:COM) disclosed on Friday the completion of its senior, secured term loan facility of up to USD22m.
Cardiome announces closing of senior, secured term loan facility
CNW Group - Fri Jul 18, 3:59PM CDT
NASDAQ: CRME, TSX: COM
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors
Business Wire - Tue Jul 15, 10:49AM CDT
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced that Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. will serve on its board of directors. The board, which was reconstituted today following the company's merger with Zalicus Inc. (Zalicus, NASDAQ: ZLCS), also includes Amit Munshi, Geoffrey Duyk, Scott Rocklage, J. Kevin Buchi and Daotian Fu.
Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:46AM CDT
Cardiome Pharma (CRME) was a big mover last session, with shares rising over 7% on the day.
Cardiome to Present at JMP Securities Healthcare Investor Conference
CNW Group - Thu Jun 19, 11:00AM CDT
NASDAQ: CRME TSX: COM
Cardiome Pharma Corp. announces voting results
PR Newswire - Tue Jun 17, 6:30AM CDT
NASDAQ: CRME TSX: COM
Cardiome Pharma Corp. Announces Additional Director Nominee for 2014 AGM
PR Newswire Europe - Wed Jun 11, 8:31AM CDT
VANCOUVER, British Columbia, June 10, 2014 /PRNewswire/ --
Cardiome to present at Bloom Burton & Co. Healthcare Investor Conference
CNW Group - Wed Jun 11, 6:30AM CDT
NASDAQ: CRME TSX: COM
Cardiome Announces Commercialization Partnership for Aggrastat(R) in Select European Markets
PR Newswire Europe - Wed Jun 11, 1:01AM CDT
VANCOUVER, May 20, 2014 /PRNewswire/ --
BioCryst Pharmaceuticals (BCRX) Soars: Stock Adds 10.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed May 28, 8:18AM CDT
BioCryst Pharmaceuticals, Inc. (BCRX) was a big mover last session, as the company saw its shares rise by almost 11% on the day.
Cardiome Pharma Has Returned 41.3% Since SmarTrend Recommendation (CRME)
Comtex SmarTrend(R) - Mon Mar 31, 4:47PM CDT
SmarTrend identified an Uptrend for Cardiome Pharma (NASDAQ:CRME) on November 21st, 2013 at $5.60. In approximately 4 months, Cardiome Pharma has returned 41.25% as of today's recent price of $7.91.
Cardiome to commercialise BRINAVESS in Greece through Vianex
M2 - Mon Mar 31, 6:10AM CDT
Canadian specialist pharmaceutical company Cardiome Pharma (NASDAQ:CRME)(TSX:COM) revealed on Friday the launch of a commercialisation and distribution of BRINAVESS (vernakalant IV) in Greece.
Cardiome Enters Agreement with VIANEX S.A. to Commercialize BRINAVESS in Greece
PR Newswire Europe - Fri Mar 28, 6:31AM CDT
VANCOUVER, British Columbia, March 28, 2014 /PRNewswire/ --
Cardiome Enters Agreement With Vianex S.A. To Commercialize BRINAVESS In Greece
CNW Group - Fri Mar 28, 6:30AM CDT
NASDAQ: CRME TSX: COM